# Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis

> **NCT04762953** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of California, Irvine** · enrollment: 40 (estimated)

## Conditions studied

- Gastric Cancer
- Peritoneal Carcinomatosis
- Gastroesophageal Junction Adenocarcinoma

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Paclitaxel
- **DRUG:** Leucovorin
- **DRUG:** Fluorouracil

## Key facts

- **NCT ID:** NCT04762953
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-02-18
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04762953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04762953, "Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04762953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*